| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |